Editas Medicine, Inc.
EDIT
$2.37
$0.2612.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 46.38M | 38.90M | 35.84M | 32.31M | 61.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.38M | 38.90M | 35.84M | 32.31M | 61.76M |
| Cost of Revenue | 111.16M | 139.02M | 177.05M | 199.25M | 220.19M |
| Gross Profit | -64.78M | -100.12M | -141.22M | -166.93M | -158.43M |
| SG&A Expenses | 54.90M | 60.68M | 66.02M | 71.99M | 70.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 166.06M | 199.70M | 243.08M | 271.23M | 290.28M |
| Operating Income | -119.68M | -160.80M | -207.24M | -238.92M | -228.52M |
| Income Before Tax | -199.84M | -236.86M | -251.23M | -237.09M | -210.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -199.84 | -236.86 | -251.23 | -237.09 | -210.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -199.84M | -236.86M | -251.23M | -237.09M | -210.57M |
| EBIT | -119.68M | -160.80M | -207.24M | -238.92M | -228.52M |
| EBITDA | -113.83M | -154.07M | -200.92M | -233.11M | -222.63M |
| EPS Basic | -2.38 | -2.85 | -3.04 | -2.88 | -2.56 |
| Normalized Basic EPS | -0.89 | -1.19 | -1.50 | -1.71 | -1.59 |
| EPS Diluted | -2.38 | -2.85 | -3.04 | -2.88 | -2.56 |
| Normalized Diluted EPS | -0.89 | -1.19 | -1.50 | -1.71 | -1.59 |
| Average Basic Shares Outstanding | 340.17M | 332.57M | 330.46M | 329.35M | 328.44M |
| Average Diluted Shares Outstanding | 340.17M | 332.57M | 330.46M | 329.35M | 328.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |